MedTrace Logo

Evaluation Of An Advanced Borderless Dressing

NCT03146845 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-05-10

Study results available
· View outcomes & findings →

Summary

This study will gather preliminary clinical, health economic, and safety data on the treatment of chronic wounds with the ALLEVYN Life Non-Bordered dressing compared to standard of care treatment when used on a wound.

Conditions

  • Pressure Ulcer
  • Leg Ulcer
  • Diabetic Foot Ulcer

Interventions

DEVICE

ALLEVYN Life Non-Bordered

Foam Dressing

DEVICE

Standard Care

Foam Dressing

Sponsors & Collaborators

  • Smith & Nephew, Inc.

    lead INDUSTRY

Principal Investigators

  • Rachael Winter · Smith & Nephew, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-15
Primary Completion
2018-06-12
Completion
2018-06-18
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03146845 on ClinicalTrials.gov